L. Li, A. M. Rojiani, and D. W. Siemann, “Preclinical Evaluations of Therapies Combining the Vascular Targeting Agent Combretastatin A-4 Disodium Phosphate and Conventional Anticancer Therapies in the Treatment of Kaposi’s Sarcoma”, AO, vol. 41, no. 1, pp. 91–97, Jan. 2002.